Literature DB >> 23427156

Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.

Natalia I Reim1, Jeremy P Kamil, Depeng Wang, Alison Lin, Mayuri Sharma, Maria Ericsson, Jean M Pesola, David E Golan, Donald M Coen.   

Abstract

Human cytomegalovirus (HCMV) encodes one conventional protein kinase, UL97. During infection, UL97 phosphorylates the retinoblastoma tumor suppressor protein (pRb) on sites ordinarily phosphorylated by cyclin-dependent kinases (CDK), inactivating the ability of pRb to repress host genes required for cell cycle progression to S phase. UL97 is important for viral DNA synthesis in quiescent cells, but this function can be replaced by human papillomavirus type 16 E7, which targets pRb for degradation. However, viruses in which E7 replaces UL97 are still defective for virus production. UL97 is also required for efficient nuclear egress of viral nucleocapsids, which is associated with disruption of the nuclear lamina during infection, and phosphorylation of lamin A/C on serine 22, which antagonizes lamin polymerization. We investigated whether inactivation of pRb might overcome the requirement of UL97 for these roles, as pRb inactivation induces CDK1, and CDK1 phosphorylates lamin A/C on serine 22. We found that lamin A/C serine 22 phosphorylation during HCMV infection correlated with expression of UL97 and was considerably delayed in UL97-null mutants, even when E7 was expressed. E7 failed to restore gaps in the nuclear lamina seen in wild-type but not UL97-null virus infections. In electron microscopy analyses, a UL97-null virus expressing E7 was as impaired as a UL97-null mutant in cytoplasmic accumulation of viral nucleocapsids. Our results demonstrate that pRb inactivation is insufficient to restore efficient viral nuclear egress of HCMV in the absence of UL97 and instead argue further for a direct role of UL97 in this stage of the infectious cycle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427156      PMCID: PMC3624322          DOI: 10.1128/JVI.00007-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.

Authors:  U Hobom; W Brune; M Messerle; G Hahn; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase.

Authors:  Paula M Krosky; Moon-Chang Baek; Wan Jin Jahng; Imma Barrera; Robert J Harvey; Karen K Biron; Donald M Coen; Phiroze B Sethna
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function.

Authors:  Laura Hertel; Edward S Mocarski
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription.

Authors:  B S Salvant; E A Fortunato; D H Spector
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  Substrates for p34cdc2: in vivo veritas?

Authors:  S Moreno; P Nurse
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

6.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

7.  Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Authors:  Karen K Biron; Robert J Harvey; Stanley C Chamberlain; Steven S Good; Albert A Smith; Michelle G Davis; Christine L Talarico; Wayne H Miller; Robert Ferris; Ronna E Dornsife; Sylvia C Stanat; John C Drach; Leroy B Townsend; George W Koszalka
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Mutations of phosphorylation sites in lamin A that prevent nuclear lamina disassembly in mitosis.

Authors:  R Heald; F McKeon
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

9.  Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase.

Authors:  Moon-Chang Baek; Paula M Krosky; Angela Pearson; Donald M Coen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

10.  The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress.

Authors:  Paula M Krosky; Moon-Chang Baek; Donald M Coen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  17 in total

1.  Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53.

Authors:  Man I Kuan; John M O'Dowd; Kamila Chughtai; Ian Hayman; Celeste J Brown; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-05       Impact factor: 3.616

2.  A Role for Myosin Va in Human Cytomegalovirus Nuclear Egress.

Authors:  Adrian R Wilkie; Mayuri Sharma; Jean M Pesola; Maria Ericsson; Rosio Fernandez; Donald M Coen
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

3.  Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex.

Authors:  Mayuri Sharma; Brian J Bender; Jeremy P Kamil; Ming F Lye; Jean M Pesola; Natalia I Reim; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

4.  Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells.

Authors:  Mayuri Sharma; Jeremy P Kamil; Margaret Coughlin; Natalia I Reim; Donald M Coen
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

5.  Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome.

Authors:  Adam Oberstein; David H Perlman; Thomas Shenk; Laura J Terry
Journal:  Proteomics       Date:  2015-05-12       Impact factor: 3.984

6.  Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress.

Authors:  Mayuri Sharma; Donald M Coen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

7.  The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress.

Authors:  Man I Kuan; John M O'Dowd; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-04       Impact factor: 3.616

8.  Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.

Authors:  Tarin M Bigley; Justin M Reitsma; Scott S Terhune
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

9.  Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.

Authors:  Denis Avey; Sarah Tepper; Benjamin Pifer; Amritpal Bahga; Hunter Williams; Joseph Gillen; Wenwei Li; Sarah Ogden; Fanxiu Zhu
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

10.  Preparation of the Human Cytomegalovirus Nuclear Egress Complex and Associated Proteins.

Authors:  Mayuri Sharma; Jeremy P Kamil; Donald M Coen
Journal:  Methods Enzymol       Date:  2015-09-11       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.